ASP Isotopes stock
ASPINASDAQASP Isotopes Inc., Basic MaterialsISIN US00218A1051
27Score 27 out of 100, Weak
Price and trend
40 / 100
Price history
−79% in one yearThe chart shows daily closes over 4 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 59% below it.
Since December 2025 the 50-day line has been below the 200-day line; the trend has turned down.
Normal: the price is neither overheated nor sold off (RSI 47).
The price is 79% below its 52-week high. Largest decline in 4 years: 89% (November 2022 to May 2023).
Chart figures for advanced users
- SMA 50$2.62
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$4.59
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)47
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDabove the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$1.72
- The lowest closing price of the last twelve months.
- Resistance$8.87
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- ASP Isotopes Inc. belongs to the Chemicals (Specialty) industry (United States) and, with a market value of $286.69M, is number 105 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $23.85M (up 475.5% year on year) and a loss of $175.09M.
- MEQIRI Score 27 out of 100 (Weak): rank 459 of 467 in Basic Materials, median 58.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
None of our strength checks applies.
Weaknesses
- DilutionShare count up 142% since 2019.Capital allocation 9
- Share price fell sharplyDown 79% over the last 12 months.Momentum 13
- Volatile share priceVolatility 100% a year over the last 12 months.Stability 42
The score is held back by momentum and capital allocation.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Score since yesterday from 26 to 27.
Fundamental quality fluctuates.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansValuation
Valuation signal
not measuredClosing price of 11 Nov 2026, used by the daily score.
No fair value can be calculated for this stock, so the signal follows the valuation grade.
Valuation metrics
No fair value can be calculated for this stock from the available figures.
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In fiscal 2025, revenue rose 476% on the prior year. Revenue has grown strongly since 2023, at around 642% per year. From 2023 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 14%, operating −240%, net −734%. Last 12 months: net −100%. From 2023 revenue is reported differently (for example gross instead of net), so earlier years are not comparable and not shown.
Debt & balance sheet
latest quarterDebt is moderate, but interest coverage is weak. Keep an eye on the interest burden and refinancing.
Earnings
- Next earnings
- 12 Nov 2026today
- Last reported
- 14 Aug 2026EPS reported −$0.28 (expected −$0.17)below expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- −$0.470.0%
- Revenue
- $25.31M0.0%
- Earnings per share
- −$0.320.0%
- Revenue
- $68.47M0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Insiders
Open-market purchases and sales by executives, board members and major holders
One insider bought on the open market in the last 6 months, $61,800 in total. 6 insiders sold, $4.95M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
- Kiessling HeatherSale
16 Oct 2026, Chief Financial Officer
- Shares
- 21,830
- Price
- $2.19
- Value
- $47,808
- Ainscow RobertSale
14 Oct 2026, COO
- Shares
- 22,500
- Price
- $2.11
- Value
- $47,565
- Ryan Robert John AndrewPurchase
30 Sept 2026, Board
- Shares
- 15,000
- Price
- $2.68
- Value
- $40,200
Show 16 more
- Ryan Robert John AndrewPurchase
28 Sept 2026, Board
- Shares
- 8,000
- Price
- $2.70
- Value
- $21,600
- Ainscow RobertSale
8 Sept 2026, COO
- Shares
- 8,438
- Price
- $4.29
- Value
- $36,216
- Mann Paul ElliotSale
4 Sept 2026, Chairman and CEO
- Shares
- 83,759
- Price
- $4.10
- Value
- $343,412
- Mann Paul ElliotSale
3 Sept 2026, Chairman and CEO
- Shares
- 83,758
- Price
- $3.92
- Value
- $328,331
- Ainscow Donald GeorgeSale
2 Sept 2026, EVP, Gen Counsel, Secretary
- Shares
- 23,678
- Price
- $3.89
- Value
- $92,107
- Ainscow RobertSale
2 Sept 2026, COO
- Shares
- 25,000
- Price
- $3.91
- Value
- $97,625
- Mann Paul ElliotSale
2 Sept 2026, Chairman and CEO
- Shares
- 83,758
- Price
- $3.91
- Value
- $327,494
- Kiessling HeatherSale
1 Jul 2026, Chief Financial Officer
- Shares
- 23,124
- Price
- $6.28
- Value
- $145,219
- Ainscow Donald GeorgeSale
30 Jun 2026, EVP, Gen Counsel, Secretary
- Shares
- 100,000
- Price
- $6.14
- Value
- $614,000
- Wider ToddSale
30 Jun 2026, Board
- Shares
- 50,000
- Price
- $6.12
- Value
- $306,000
- Gorley MichaelSale
30 Jun 2026, Board
- Shares
- 30,000
- Price
- $6.27
- Value
- $188,100
- Wider ToddSale
29 Jun 2026, Board
- Shares
- 50,000
- Price
- $6.25
- Value
- $312,500
- Ainscow RobertSale
8 Jun 2026, COO
- Shares
- 8,438
- Price
- $7.00
- Value
- $59,058
- Mann Paul ElliotSale
3 Jun 2026, Chairman and CEO
- Shares
- 83,759
- Price
- $7.76
- Value
- $649,970
- Mann Paul ElliotSale
2 Jun 2026, Chairman and CEO
- Shares
- 83,758
- Price
- $8.29
- Value
- $694,354
- Mann Paul ElliotSale
1 Jun 2026, Chairman and CEO
- Shares
- 83,758
- Price
- $7.88
- Value
- $660,013
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at ASP Isotopes
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 27
- Sector median
- 58
Categories against the sector medianMedian of 467 companies
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Plastika KritisPLAKR.AT $463.07M67
- GevoGEVO $449.97M42
- AdvanSixASIX $416.74M42
- Rayonier Advanced MaterialsRYAM $374.07M26
- Uzin UtzUZU.DE $365.96M55
- H&R GmbH & Co. KGaA2HRA.DE $280.8M61
- MasterflexMZX.DE $153.58M69
- NabaltecNTG.DE $108.2M51
ETFs that hold ASP Isotopes
Held by 9 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.01% | 0.30% | €2.17B |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.01% | 0.30% | €4.22B |
| iShares MSCI World Small Cap CTB Enhanced ESG UCITS ETFCBUG | 0.01% | 0.35% | €434.1M |
Show 5 more
| State Street SPDR MSCI World Small Cap UCITS ETF (Acc)ZPRS | 0.00% | 0.45% | €1.53B |
| iShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETFSXRG | 0.00% | 0.43% | €2.48B |
| State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETFZPRV | 0.00% | 0.30% | €944.34M |
| UBS MSCI USA Select Factor Mix UCITS ETF USD accUSUE | 0.00% | 0.25% | €175.89M |
| State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)SPYI | 0.00% | 0.17% | €8.6B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Nov 2023)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.